UMMC epidemiologist Prof Dr Nirmala touts Asean-level drug procurement to improve access to life-saving cancer meds, particularly high-cost drugs that extend survival to over 5 years. She also suggests localised dose-optimisation trials for cancer drugs. https://codeblue.galencentre.org/2025/06/ummc-epidemiologist-touts-asean-procurement-of-magic-bullet-cancer-drugs/